Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial.

Details

Language :

English

ISSN :

20959907

Volume :

10

Issue :

1

Database :

Complementary Index

Journal :

Signal Transduction & Targeted Therapy

Publication Type :

Academic Journal

Accession number :

182278964

Full Text :

https://doi.org/10.1038/s41392-024-02116-4